GS-5737

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GS-5737, covering 2014-03-20 to 2014-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF [Phase 1]